Surface Oncology, Inc. Common Stock
SURF
SURF was delisted on the 7th of September, 2023.
44 hedge funds and large institutions have $145M invested in Surface Oncology, Inc. Common Stock in 2020 Q2 according to their latest regulatory filings, with 21 funds opening new positions, 11 increasing their positions, 5 reducing their positions, and 6 closing their positions.
470% more capital invested
Capital invested by funds: $25.5M → $145M (+$120M)
250% more first-time investments, than exits
New positions opened: 21 | Existing positions closed: 6
120% more repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 5
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
52% more funds holding
Funds holding: 29 → 44 (+15)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VA
VR Adviser
New York
|
+$14M |
| 2 |
EC
EcoR1 Capital
San Francisco,
California
|
+$13.6M |
| 3 |
APM
Avidity Partners Management
Dallas,
Texas
|
+$5.34M |
| 4 |
BI
BVF Inc
San Francisco,
California
|
+$3.81M |
| 5 |
GTC
Ghost Tree Capital
New York
|
+$2.53M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NMC
NEA Management Company
Timonium,
Maryland
|
-$6.2M |
| 2 |
Fidelity International
Hamilton,
Bermuda
|
-$1.21M |
| 3 |
Millennium Management
New York
|
-$759K |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$528K |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$489K |
SURF Hedge Fund Activity: Q2 2020 in Review
44 of the 4,888 institutional investors tracked by Wall St. Rank reported a position in Surface Oncology, Inc. Common Stock (SURF) for Q2 2020, worth a combined $145M — up 470% from $25.5M a quarter earlier.
Buyers outnumbered sellers: 21 funds opened new SURF positions and 6 closed out — a net gain of 15 holders — while 11 added to existing stakes and 5 trimmed.
The largest buyer was VR Adviser, opening a new position worth an estimated $14M. The largest seller was NEA Management Company, exiting entirely with an estimated $6.2M sold.
- 44 institutional investors held Surface Oncology, Inc. Common Stock (SURF) as of Q2 2020, up from 29 in Q1 2020.
- Funds reported $145M of Surface Oncology, Inc. Common Stock stock for Q2 2020, up 470% quarter-over-quarter.
- 21 funds opened new Surface Oncology, Inc. Common Stock positions in Q2 2020 and 6 closed out, a net change of +15 holders.
- The largest Surface Oncology, Inc. Common Stock buyer in Q2 2020 was VR Adviser, an estimated $14M added.
- The largest Surface Oncology, Inc. Common Stock seller in Q2 2020 was NEA Management Company, an estimated $6.2M sold.
Based on aggregated 13F filings for Q2 2020.